LeukoPax Collections

LeukoPax is dedicated to advancing cell therapy development through specialized donor qualification and leukopak collections. We connect cell therapy developers with precisely matched, qualified donors, ensuring their unique requirements are met. Our innovative stewardship and collection practices foster long-term donor commitment. At LeukoPax, our unwavering dedication to customer service drives innovation and supports the future of cell therapy.  

The LeukoPax team is currently collaborating with our strategic partners to test and qualify donors for leukopak collections. We are identifying donors whose cells perform best in experiments assessing intrinsic and extrinsic cellular properties, a qualification process powered by sophisticated AI algorithms. These donors will be comprehensively annotated and eligible for leukopak collections.


To request more information or join the waiting list to order a Full-Pax™ or Half-Pax™ from these highly qualified donors, fill out the form below.


We anticipate starting collections from characterized donors in July 2025.